Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Acta Neuropathologica|January 3, 2025
Detection of H3F3A K27M or BRAF V600E in liquid biopsies of brain tumor patients as diagnostic and monitoring biomarker: impact of tumor localization and sampling methodSibylle Madlener, Natalia Stepien, Daniel Senfter, et al.
EMBO Molecular Medicine|February 6, 2023
A whole-genome scan for Artemisinin cytotoxicity reveals a novel therapy for human brain tumorsJasmin Taubenschmid-Stowers, Michael Orthofer, Anna Laemmerer, et al.
Neuro-Oncology|April 4, 2017
Telomerase activation in posterior fossa group A ependymomas is associated with dismal prognosis and chromosome 1q gainJohannes Gojo, Daniela Lötsch, Sabine Spiegl-Kreinecker, et al.
European Journal of Radiology|July 12, 2026
Assessment of treatment response in recurrent medulloblastoma using craniospinal MRIJuliane Hennenberg, Leo Hofer, Bence Nemeth, et al.
Journal of Personalized Medicine|April 30, 2021
Novel Insights into Diagnosis, Biology and Treatment of Primary Diffuse Leptomeningeal MelanomatosisAlicia Baumgartner, Natalia Stepien, Lisa Mayr, et al.
Frontiers in Oncology|January 31, 2020
Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic OpportunitiesJohannes Gojo, Zdenek Pavelka, Danica Zapletalova, et al.
JAMA Oncology|October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled TrialAndreas Peyrl, Monika Chocholous, Magnus Sabel, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|July 11, 2025
Glucocorticoid use in paediatric posterior fossa tumour surgery and the occurrence of postoperative speech impairmentRebekka Sarup, Aske F Laustsen, Martin K Sørensen, et al.
Journal of Personalized Medicine|December 23, 2020
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated <i>ROS1/NTRK</i>-Fusion Positive Pediatric High-Grade GliomaLisa Mayr, Armin S Guntner, Sibylle Madlener, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 16, 2026
Co-targeting CDK4/6 and MEK reverses mesenchymal transition in therapy-refractory BRAF-altered pediatric high-grade gliomaLisa Mayr, Leah Mager, Lisa Gabler-Pamer, et al.
Pageof 8